<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59073</article-id><article-id pub-id-type="doi">10.7554/eLife.59073</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-189409"><name><surname>Orlando</surname><given-names>Krystal Ann</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189419"><name><surname>Douglas</surname><given-names>Amber K</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189420"><name><surname>Abudu</surname><given-names>Aierken</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189421"><name><surname>Wang</surname><given-names>Yemin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219663"><name><surname>Tessier-Cloutier</surname><given-names>Basile</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219664"><name><surname>Su</surname><given-names>Weiping</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219665"><name><surname>Peters</surname><given-names>Alec</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12651"><name><surname>Sherman</surname><given-names>Larry S</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219666"><name><surname>Moore</surname><given-names>Rayvon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219667"><name><surname>Nguyen</surname><given-names>Vinh</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189422"><name><surname>Negri</surname><given-names>Gian Luca</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7722-8888</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189423"><name><surname>Colborne</surname><given-names>Shane</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56566"><name><surname>Morin</surname><given-names>Gregg B</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219805"><name><surname>Kommoss</surname><given-names>Friedrich</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189424"><name><surname>Lang</surname><given-names>Jessica D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9700-4785</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189425"><name><surname>Hendricks</surname><given-names>William PD</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189426"><name><surname>Raupach</surname><given-names>Elizabeth A</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189427"><name><surname>Pirrotte</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148855"><name><surname>Huntsman</surname><given-names>David G</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189428"><name><surname>Trent</surname><given-names>Jeffrey M</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189429"><name><surname>Parker</surname><given-names>Joel S</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-189430"><name><surname>Raab</surname><given-names>Jesse R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6387-8994</contrib-id><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-188662"><name><surname>Weissman</surname><given-names>Bernard E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1827-2309</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pathology and Laboratory Medicine; Lineberger Comprehensive Cancer Center</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Lineberger Comprehensive Cancer Center</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Mirobiology and Molecular Genetics</institution>, <institution>Michigan State University</institution>, <addr-line><named-content content-type="city">East Lansing</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Pathology and Laboratory Medicine</institution>, <institution>University of British Columnia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution content-type="dept">Cell, Developmental, and Cancer Biology</institution>, <institution>Oregon Health &amp; Science University</institution>, <addr-line><named-content content-type="city">Beaverton</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Division of Neuroscience, Oregon National Primate Research Center</institution>, <institution>Oregon Health &amp; Science University</institution>, <addr-line><named-content content-type="city">Beaverton</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Curriculum in Toxicology and Environmental Medicine; Lineberger Comprehensive Cancer Center</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Michael Smith Genome Science Centre</institution>, <institution>British Columbia Cancer Agency</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><aff id="aff9"><institution content-type="dept">Genome Sciences</institution>, <institution>British Columbia Cancer Agency</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><aff id="aff10"><institution content-type="dept">Institute of Pathology</institution>, <institution>Synlab MVZ Pathologie</institution>, <addr-line><named-content content-type="city">Mannheim</named-content></addr-line>, <country>Germany</country></aff><aff id="aff11"><institution content-type="dept">Division of Integrated Cancer Genomics</institution>, <institution>Translational Genomics Research Institute</institution>, <addr-line><named-content content-type="city">Phoenix</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution content-type="dept">Collaborative Center for Translational Mass Spectrometry</institution>, <institution>Translational Genomics Research Institute</institution>, <addr-line><named-content content-type="city">Phoenix</named-content></addr-line>, <country>United States</country></aff><aff id="aff13"><institution>British Columbia Cancer Research Institute</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><aff id="aff14"><institution content-type="dept">Department of Genetics; Lineberger Comprehensive Cancer Center</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff15"><institution content-type="dept">Department of Genetics</institution>, <institution>University of North Carolina at Chapel Hill</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-33764"><name><surname>Murphy</surname><given-names>Maureen E</given-names></name><role>Reviewing editor</role><aff><institution>The Wistar Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jesse_raab@med.unc.edu</email> (JR);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>weissman@med.unc.edu</email> (BW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>12</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e59073</elocation-id><history><date date-type="received"><day>19</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Orlando et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Orlando et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-59073-v1.pdf"/><abstract><p>Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive form of ovarian cancer. SCCOHT tumors have inactivating mutations in <italic>SMARCA4 </italic>(BRG1), one of the two mutually exclusive ATPases of the SWI/SNF chromatin remodeling complex. To address the role that BRG1 loss plays in SCCOHT tumorigenesis, we performed integrative multi-omic analyses in SCCOHT cell lines +/- BRG1 re-expression. BRG1 re-expression induced a gene and protein signature similar to an epithelial cell and gained chromatin accessibility sites correlated with other epithelial originating TCGA tumors. Gained chromatin accessibility and BRG1 recruited sites were strongly enriched for transcription factor binding motifs of AP-1 family members. Furthermore, AP-1 motifs were enriched at the promoters of highly upregulated epithelial genes. Using a dominant negative AP-1 cell line, we found that both AP-1 DNA binding activity and BRG1 re-expression are necessary for the gene and protein expression of epithelial genes. Our study demonstrates that BRG1 re-expression drives an epithelial-like gene and protein signature in SCCOHT cells that depends upon by AP-1 activity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01CA195670</award-id><principal-award-recipient><name><surname>Huntsman</surname><given-names>David G</given-names></name><name><surname>Trent</surname><given-names>Jeffrey M</given-names></name><name><surname>Weissman</surname><given-names>Bernard E</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30CA016086</award-id><principal-award-recipient><name><surname>Parker</surname><given-names>Joel S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32ES007126</award-id><principal-award-recipient><name><surname>Nguyen</surname><given-names>Vinh</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Department of Defense</institution></institution-wrap></funding-source><award-id>W81XWH-19-1-0423</award-id><principal-award-recipient><name><surname>Raab</surname><given-names>Jesse R</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P51 OD 011092</award-id><principal-award-recipient><name><surname>Sherman</surname><given-names>Larry S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Raw fastq files and processed data have been deposited in Gene Expression Omnibus (GEO) database with the accession number: GSE151026. Proteomics data was deposited in PRIDE database (accession #PXD014134).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Orlando KA et al</collab></person-group><year iso-8601-date="2020">2020</year><source>Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151026">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151026</ext-link><comment>NCBI Gene Expression Omnibus, GSE151026</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Orlando KA et al</collab></person-group><year iso-8601-date="2020">2020</year><source>SMARCA4 regulates an epithelial-like gene signature through AP-1 driven mechanisms in Small Cell Carcinoma of Ovary- Hypercalcemic Type</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD014134">https://www.ebi.ac.uk/pride/archive/projects/PXD014134</ext-link><comment>PRIDE, PXD014134</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Pan J et al</collab></person-group><year iso-8601-date="2019">2019</year><source>The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117735">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117735</ext-link><comment>NCBI Gene Expression Omnibus, GSE117735</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Xue Y et al</collab></person-group><year iso-8601-date="2019">2019</year><source>CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I)</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120297">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120297</ext-link><comment>NCBI Gene Expression Omnibus, GSE120297</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Song et al</collab></person-group><year iso-8601-date="2020">2020</year><source>Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162611">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162611</ext-link><comment>NCBI Gene Expression Omnibus, GSE162611</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-59073-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>